Form 4: Perimeter Solutions Director's Stock Option Vesting
Insider Transaction Report
Perimeter Solutions Director Bernt G Iversen II reported the vesting of 35,682 stock options based on 2025 performance criteria.
Summary
- Director Bernt G Iversen II reported the vesting of multiple stock option grants on February 26, 2026.
- A total of 35,682 shares underlying stock options vested, tied to the Issuer's satisfaction of performance criteria for the fiscal year ending December 31, 2025.
- For two grants (December 23, 2025, and February 12, 2025), performance criteria for 2025 were partially met, resulting in the vesting of 2,655 and 6,194 shares, respectively.
- For four other grants (February 14, 2024; February 15, 2023; September 6, 2023; May 3, 2022), performance criteria for 2025 were fully met, resulting in the vesting of 7,000, 7,000, 7,000, and 5,833 shares, respectively.
- The options have various exercise prices ranging from $5.23 to $27.84.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a routine insider transaction reflecting the vesting of equity compensation. The mixed results on performance criteria (some fully met, some partially met) suggest a neutral to slightly positive sentiment regarding the underlying company performance for 2025.
Positives
- Performance criteria for 2025 were fully met for four separate stock option grants, leading to the expected vesting of 26,833 shares.
- The vesting of options indicates continued alignment of director incentives with company performance.
Negatives
- Performance criteria for 2025 were only partially met for two stock option grants, resulting in a lower number of vested shares (2,655 and 6,194) than the full annual installment for those specific grants.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions and do not typically provide broader industry context. This filing reflects standard equity compensation practices for directors.
Stakeholder Impact
- Shareholders: The vesting of options increases the potential for dilution if exercised, but also aligns director incentives with shareholder value creation.
- Employees: Reflects the company's compensation structure for its directors, which may be indicative of broader equity compensation practices.
Next Steps
- Continued vesting of remaining installments of the stock options based on future performance criteria for fiscal years ending December 31, 2026, 2027, 2028, and 2029, as applicable to each grant.
Key Dates
| Date | Description |
|---|---|
| 2022-05-03 | Grant date for an option to purchase 29,167 shares of common stock. |
| 2023-02-15 | Grant date for an option to purchase 35,000 shares of common stock. |
| 2023-09-06 | Grant date for an option to purchase 35,000 shares of common stock. |
| 2024-02-14 | Grant date for an option to purchase 35,000 shares of common stock. |
| 2025-02-12 | Grant date for an option to purchase 35,000 shares of common stock. |
| 2025-12-23 | Grant date for an option to purchase 15,000 shares of common stock. |
| 2025-12-31 | Fiscal year end for which performance criteria were evaluated for option vesting. |
| 2026-02-26 | Date of reported transaction (stock option vesting). |
| 2026-03-02 | Date the Form 4 was signed. |
| 2032-05-03 | Expiration date for the option granted on May 3, 2022. |
| 2033-02-15 | Expiration date for the option granted on February 15, 2023. |
| 2033-09-06 | Expiration date for the option granted on September 6, 2023. |
| 2034-02-14 | Expiration date for the option granted on February 14, 2024. |
| 2035-02-12 | Expiration date for the option granted on February 12, 2025. |
| 2035-12-23 | Expiration date for the option granted on December 23, 2025. |
Recommendation
holdThis Form 4 filing details routine vesting of stock options for a director based on previously established performance criteria. It does not provide new material information about the company's financial health, strategic direction, or operational performance that would warrant a change in investment recommendation. The mixed performance criteria results (some met, some partially met) for 2025 are not significant enough to alter a fundamental view of the stock, thus a 'hold' recommendation is appropriate.
Keywords
Perimeter Solutions, PRM, Stock Options, Director Compensation, SEC Form 4, Beneficial Ownership, Equity Compensation, Performance Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.